These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6287349)

  • 41. Morphine catalepsy in the rat: involvement of mu 1 (high affinity) opioid binding sites.
    Ling GS; Pasternak GW
    Neurosci Lett; 1982 Oct; 32(2):193-6. PubMed ID: 6292799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.
    Tulunay FC; Ayhan IH; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1981 Mar; 70(2):219-24. PubMed ID: 6266844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor.
    Nozaki M; Cho TM
    J Neurochem; 1985 Aug; 45(2):461-4. PubMed ID: 2989428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro.
    Benyhe S; Hoffmann G; Varga E; Hosztafi S; Toth G; Borsodi A; Wollemann M
    Life Sci; 1989; 44(24):1847-57. PubMed ID: 2472540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone.
    Holaday JW; Pasternak GW; D'Amato RJ; Ruvio BA; Faden AI
    Eur J Pharmacol; 1983 May; 89(3-4):293-6. PubMed ID: 6307712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of [3H]-oxymorphazone and its binding to rat brain membranes.
    Borsodi A; Varga E; Toth G; Hosztafi S
    NIDA Res Monogr; 1986; 75():220-3. PubMed ID: 2448626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphine analgesia and cerebral opiate receptors: a developmental study.
    Auguy-Valette A; Cros J; Gouarderes C; Gout R; Pontonnier G
    Br J Pharmacol; 1978 Jun; 63(2):303-8. PubMed ID: 208703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.
    Agmo A; Rojas J; Vázquez P
    Psychopharmacology (Berl); 1992; 107(1):89-96. PubMed ID: 1317041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression.
    Shook JE; Watkins WD; Camporesi EM
    Am Rev Respir Dis; 1990 Oct; 142(4):895-909. PubMed ID: 2171388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced mu-subtype to delta-subtype changes.
    Mosqueda-Garcia R; Kunos G
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8637-41. PubMed ID: 2825200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia.
    Hynes MD; Frederickson RC
    Life Sci; 1982 Sep 20-27; 31(12-13):1201-4. PubMed ID: 6292609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites.
    Hahn EF; Pasternak GW
    Life Sci; 1982 Sep 20-27; 31(12-13):1385-8. PubMed ID: 6292633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple opiate receptors: phylogenetic differences.
    Buatti MC; Pasternak GW
    Brain Res; 1981 Aug; 218(1-2):400-5. PubMed ID: 6268247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators.
    Messing RB; Portoghese PS; Takemori AE; Sparber SB
    Pharmacol Biochem Behav; 1982 Apr; 16(4):621-6. PubMed ID: 6280206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and binding of 3H-oxymorphazone to rat brain membranes.
    Varga E; Toth G; Benyhe S; Hosztafi S; Borsodi A
    Life Sci; 1987 Apr; 40(16):1579-88. PubMed ID: 2436019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.